Health‐Related Quality of Life in Patients With Systemic Autoimmune Rheumatic Diseases (SARD) and Post‐COVID Syndrome: A Case‐Control Study
Musculoskeletal Care · 2025
DOI: 10.1002/msc.70123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Musculoskeletal Care, 2025. Verfasst von Pamela Munguía-Realpozo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Systemic Rheumatic and Autoimmune Diseases Research Unit, Hospital de Especialidades UMAE-CIBIOR, Instituto Mexicano del Seguro Social, Puebla, Mexic…. Hauptthemen laut MEDLINE: COVID-19, Quality of Life, Autoimmune Diseases, Rheumatic Diseases. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objective
To assess the prevalence and characteristics of the post‐COVID syndrome and its effect on the health‐related quality of life (HRQOL) of COVID‐19‐recovered patients with SARD.
Methods
This cross‐sectional study included patients over 18 years old with systemic autoimmune rheumatic diseases (SARDs) in addition to sex‐ and age‐matched controls without SARDs who tested positive for SARS‐CoV‐2. Sociodemographic variables and clinical data related to the infection and its severity were collected using EuroQol‐5 dimensions‐5 levels (EQ‐5D‐5L) and EuroQol‐visual analogue scales (EQ‐VAS).
Results
We included 58 patients with SARD and 116 controls. Post‐COVID syndrome was observed in 39 (67.2%) of SARD patients and 86.2% of the controls ( p < 0.001). The most frequent post‐COVID syndrome symptoms were fatigue (74.4%), anosmia (35.9%), and dysgeusia (28.2%). The EQ‐VAS score was lower in patients with SARD than in controls (62.4 ± 18.6 vs. 80.9 ± 7.3; p < 0.001). Similarly, SARD patients with post‐COVID syndrome had lower EQ‐VAS than those without post‐COVID syndrome VAS = 62.4 ± 18.6 versus 75.9 ± 14.9; p = 0.011.
Conclusions
We found that 67.2% of patients with SARDs affected by COVID‐19 presented with persistent symptoms. However, patients with SARD showed significantly lower HRQL than patient controls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Systemic Rheumatic and Autoimmune Diseases Research Unit, Hospital de Especialidades UMAE-CIBIOR, Instituto Mexicano del Seguro Social, Puebla, Mexico.
- Department of Rheumatology, Medicine School, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
- Unidad de Medicina Familiar 11, Instituto Mexicano del Seguro Social, Puebla, Mexico.
- Unidad de Medicina Familiar 34, Instituto Mexicano del Seguro Social, Atlixco, Mexico.
ORCID-Profile: Pamela Munguía-Realpozo, Claudia Mendoza-Pinto, Sandra Ibañez-Ovando, Ana Luisa Roco-Zúñiga, Jesús Texis-Ramírez, Juan Serrano-Ramírez, Ivet Etchegaray-Morales
Zitieren
APA
Munguía-Realpozo, P., Mendoza-Pinto, C., Ibañez-Ovando, S., Roco-Zúñiga, A. L., Texis-Ramírez, J., Serrano-Ramírez, J., & Etchegaray-Morales, I. (2025). Health‐Related Quality of Life in Patients With Systemic Autoimmune Rheumatic Diseases (SARD) and Post‐COVID Syndrome: A Case‐Control Study. Musculoskeletal Care. https://doi.org/10.1002/msc.70123
Vancouver
Munguía-Realpozo P, Mendoza-Pinto C, Ibañez-Ovando S, Roco-Zúñiga AL, Texis-Ramírez J, Serrano-Ramírez J, et al. Health‐Related Quality of Life in Patients With Systemic Autoimmune Rheumatic Diseases (SARD) and Post‐COVID Syndrome: A Case‐Control Study. Musculoskeletal Care. 2025. doi:10.1002/msc.70123
BibTeX
@article{MunguaRealpozo2025,
author = {Munguía-Realpozo, Pamela and Mendoza-Pinto, Claudia and Ibañez-Ovando, Sandra and Roco-Zúñiga, Ana Luisa and Texis-Ramírez, Jesús and Serrano-Ramírez, Juan and Etchegaray-Morales, Ivet},
title = {Health‐Related Quality of Life in Patients With Systemic Autoimmune Rheumatic Diseases (SARD) and Post‐COVID Syndrome: A Case‐Control Study},
journal = {Musculoskeletal Care},
year = {2025},
doi = {10.1002/msc.70123}
}
EUVIMED